These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11866966)

  • 21. Vimentin-positive adenocarcinomas of the stomach: co-expression of vimentin and cytokeratin.
    Utsunomiya T; Yao T; Masuda K; Tsuneyoshi M
    Histopathology; 1996 Dec; 29(6):507-16. PubMed ID: 8971557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic ovarian carcinoma of large intestinal origin simulating primary ovarian carcinoma. A clinicopathologic study of 25 cases.
    Daya D; Nazerali L; Frank GL
    Am J Clin Pathol; 1992 Jun; 97(6):751-8. PubMed ID: 1595595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic adenocarcinoma to the brain: an immunohistochemical approach.
    Perry A; Parisi JE; Kurtin PJ
    Hum Pathol; 1997 Aug; 28(8):938-43. PubMed ID: 9269830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian metastases: computed tomographic appearances.
    Megibow AJ; Hulnick DH; Bosniak MA; Balthazar EJ
    Radiology; 1985 Jul; 156(1):161-4. PubMed ID: 4001405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.
    Brown RW; Campagna LB; Dunn JK; Cagle PT
    Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear reactivity for estrogen. A possible diagnostic tool in differentiating colon cancer metastases in the ovary from primary mucinous ovarian tumors.
    Darwish SA; D'Ablaing G; Taylor CR
    Cancer; 1988 Nov; 62(10):2203-6. PubMed ID: 3179933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas.
    Loy TS; Calaluce RD
    Am J Clin Pathol; 1994 Dec; 102(6):764-7. PubMed ID: 7528468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical detection of breast specific antigens and cytokeratins in metastatic breast carcinoma in the liver.
    Akasofu M; Kawahara E; Kurumaya H; Nakanishi I
    Acta Pathol Jpn; 1993 Dec; 43(12):736-44. PubMed ID: 7509105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinoma of Unknown Primary Origin: Application of Immunohistochemistry With Emphasis to Different Cytokeratin 7 and 20 Staining Patterns.
    Mokhtari M; Safavi D; Soleimani N; Monabati A; Safaei A
    Appl Immunohistochem Mol Morphol; 2022 Oct; 30(9):623-634. PubMed ID: 36036642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal adenocarcinomas metastatic to the ovaries. A clinicopathologic evaluation of 22 cases.
    Lash RH; Hart WR
    Am J Surg Pathol; 1987 Feb; 11(2):114-21. PubMed ID: 3812871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the transitional mucosa of the colon in differentiating primary adenocarcinoma from carcinomas metastatic to the colon. An immunohistochemical study.
    Sawady J; Friedman MI; Katzin WE; Mendelsohn G
    Am J Surg Pathol; 1991 Feb; 15(2):136-44. PubMed ID: 1989461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoembryonic antigen in primary and metastatic ovarian tumors.
    Fleuren GJ; Nap M
    Gynecol Oncol; 1988 Jul; 30(3):407-15. PubMed ID: 2839395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of colon-ovarian tumor antigen in adenocarcinomas. An immunohistochemical study of 501 cases.
    Loy TS; Darkow GV
    Am J Clin Pathol; 1993 Feb; 99(2):207-10. PubMed ID: 7679875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human alveolar macrophage-56 and carcinoembryonic antigen monoclonal antibodies in the differential diagnosis between primary ovarian and metastatic gastrointestinal carcinomas.
    Fowler LJ; Maygarden SJ; Novotny DB
    Hum Pathol; 1994 Jul; 25(7):666-70. PubMed ID: 8026826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of intermediate filaments in ovarian and uterine tumors.
    Bonazzi del Poggetto C; Virtanen I; Lehto VP; Wahlström T; Saksela E
    Int J Gynecol Pathol; 1983; 1(4):359-66. PubMed ID: 6193074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of new ovarian and colon carcinoma cell lines: differentiation is only possible by cytokeratin analysis.
    Möbus VJ; Moll R; Gerharz CD; Kieback DG; Weikel W; Hoffmann G; Kreienberg R
    Br J Cancer; 1994 Mar; 69(3):422-8. PubMed ID: 7510115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites.
    Kaufmann O; Deidesheimer T; Muehlenberg M; Deicke P; Dietel M
    Histopathology; 1996 Sep; 29(3):233-40. PubMed ID: 8884351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermediate filaments in rat pancreatic acinar tumors, human ductal carcinomas, and other gastrointestinal malignancies.
    Herzig KH; Altmannsberger M; Fölsch UR
    Gastroenterology; 1994 May; 106(5):1326-32. PubMed ID: 7513668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic adenocarcinoma of an unknown primary site. A comparison of the relative contributions of morphology, minimal essential clinical data and CEA immunostaining status.
    Sheahan K; O'Keane JC; Abramowitz A; Carlson JA; Burke B; Gottlieb LS; O'Brien MJ
    Am J Clin Pathol; 1993 Jun; 99(6):729-35. PubMed ID: 8322709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases.
    Prat J; Matias-Guiu X; Barreto J
    Cancer; 1991 Dec; 68(11):2455-9. PubMed ID: 1933783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.